Ken Iwai

1.1k total citations
10 papers, 782 citations indexed

About

Ken Iwai is a scholar working on Cancer Research, Hepatology and Molecular Biology. According to data from OpenAlex, Ken Iwai has authored 10 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 4 papers in Hepatology and 3 papers in Molecular Biology. Recurrent topics in Ken Iwai's work include Cancer, Hypoxia, and Metabolism (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer Research and Treatments (2 papers). Ken Iwai is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer Research and Treatments (2 papers). Ken Iwai collaborates with scholars based in Japan and Bangladesh. Ken Iwai's co-authors include Toshimitsu Konno, Hiroshi Maeda, Shôjirô Maki, Seiki Tashiro, Hiroshi Maeda, Tetsuo Morinaga, Mizuho Mochinaga, Ikuzō Yokoyama, Takehisa Hiraoka and Hiroshi Maeda and has published in prestigious journals such as Cancer, British journal of surgery and Bioscience Biotechnology and Biochemistry.

In The Last Decade

Ken Iwai

10 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Iwai Japan 5 359 217 190 188 159 10 782
Liteng Lin China 18 280 0.8× 206 0.9× 163 0.9× 368 2.0× 234 1.5× 39 1.1k
Arris J. Henderson United States 8 177 0.5× 98 0.5× 186 1.0× 454 2.4× 424 2.7× 8 1.0k
Gunnar Schütz Germany 9 300 0.8× 52 0.2× 150 0.8× 353 1.9× 530 3.3× 15 1.2k
Susanne Arns Germany 11 83 0.2× 106 0.5× 51 0.3× 137 0.7× 140 0.9× 13 532
S. Colombatto Italy 5 189 0.5× 69 0.3× 36 0.2× 117 0.6× 54 0.3× 9 613
Heping Li China 19 77 0.2× 91 0.4× 503 2.6× 755 4.0× 232 1.5× 47 1.2k
Yesen Li China 15 47 0.1× 100 0.5× 85 0.4× 307 1.6× 171 1.1× 45 766
Maria Kissel Germany 9 47 0.1× 108 0.5× 57 0.3× 166 0.9× 72 0.5× 13 408
Caterina Malcontenti‐Wilson Australia 13 105 0.3× 27 0.1× 64 0.3× 112 0.6× 107 0.7× 21 426
Brian R. Stoll United States 10 40 0.1× 158 0.7× 292 1.5× 542 2.9× 398 2.5× 11 1.1k

Countries citing papers authored by Ken Iwai

Since Specialization
Citations

This map shows the geographic impact of Ken Iwai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Iwai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Iwai more than expected).

Fields of papers citing papers by Ken Iwai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Iwai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Iwai. The network helps show where Ken Iwai may publish in the future.

Co-authorship network of co-authors of Ken Iwai

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Iwai. A scholar is included among the top collaborators of Ken Iwai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Iwai. Ken Iwai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Iwai, Ken, et al.. (2023). Adaptability of the Sense of Agency in Healthy Young Adults in Sensorimotor Tasks for a Short Term. Behavioral Sciences. 13(2). 132–132. 2 indexed citations
2.
Matsuda, Yusuke, Ken Iwai, Akira Saito, et al.. (2014). Characterization of a yam class IV chitinase produced by recombinant Pichia pastoris X-33. Bioscience Biotechnology and Biochemistry. 78(2). 222–230. 3 indexed citations
3.
Hiraoka, Takehisa, et al.. (1986). Metastases from hepatocellular carcinoma in sclerosed oesophageal varices in cirrhotic patients. British journal of surgery. 73(11). 932–932. 2 indexed citations
4.
Maki, Shôjirô, et al.. (1986). [CT image of the liver cancer after administration of SMANCS/lipiodol].. PubMed. 13(4 Pt 2). 1603–10. 1 indexed citations
5.
Iwai, Ken, Hiroshi Maeda, & Toshimitsu Konno. (1984). Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.. PubMed. 44(5). 2115–21. 234 indexed citations
6.
Maeda, Hiroshi, Tomonori Matsumoto, Toshimitsu Konno, Ken Iwai, & Minoru Ueda. (1984). Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancs. Journal of Protein Chemistry. 3(2). 181–193. 79 indexed citations
7.
Konno, Toshimitsu, Hiroshi Maeda, Ken Iwai, et al.. (1984). Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium. Cancer. 54(11). 2367–2374. 182 indexed citations
8.
Maeda, Hideki, et al.. (1984). [Tumor selective drug delivery with lipid contrast medium (smancs/lipiodol): sustained antitumor effect, enhanced diagnostic value and quantification of dosage regimen].. PubMed. 11(4). 814–26. 3 indexed citations
9.
Konno, Toshimitsu, Hiroshi Maeda, Ken Iwai, et al.. (1983). Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. European Journal of Cancer and Clinical Oncology. 19(8). 1053–1065. 265 indexed citations
10.
Konno, Tasuku, Hajime Maeda, Ikuzō Yokoyama, et al.. (1982). [Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma].. PubMed. 9(11). 2005–15. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026